ProMIS Neurosciences, Inc. (PMN)
R&D Expenses
$35.66M
TTM · Period ending: · USD
PMN R&D Expenses
Latest reported$35.66Mperiod ending
Latest reported$35.66Mperiod ending
PMN TTM R&D Expenses ($2.15M → $35.66M)
TTM R&D Expenses
High-resolution chart · PNG
PMN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 35,658,085 | |
| 34,886,076 | |
| 33,379,321 | |
| 28,336,055 | |
| 21,102,411 | |
| 13,978,448 | |
| 10,637,976 | |
| 8,538,411 | |
| 7,116,797 | |
| 6,823,310 | |
| 9,447,258 | |
| 15,800,291 | |
| 20,923,568 | |
| 23,749,554 | |
| 21,379,365 | |
| 15,828,144 | |
| 10,368,099 | |
| 7,064,925 | |
| 4,963,375 | |
| 2,193,432 | |
| 2,441,809 | |
| 2,485,550 | |
| 3,183,149 | |
| 3,795,165 | |
| 3,794,519 | |
| 3,938,250 | |
| 4,290,664 | |
| 6,836,991 | |
| 7,229,404 | |
| 7,350,786 | |
| 6,565,285 | |
| 3,636,886 | |
| 3,185,540 | |
| 2,892,132 | |
| 2,907,032 | |
| 3,125,109 | |
| 2,505,679 | |
| 1,878,580 | |
| 1,601,665 | |
| 1,130,773 | |
| 1,028,961 | |
| 876,204 | |
| 780,998 | |
| 955,554 | |
| 1,062,568 | |
| 1,476,356 | |
| 1,636,221 | |
| 1,505,465 | |
| 1,440,254 | |
| 1,358,949 | |
| 1,447,900 | |
| 1,586,143 | |
| 1,731,329 | |
| 1,762,185 | |
| 1,330,655 | |
| 1,482,862 | |
| 1,519,417 | |
| 1,494,805 | |
| 2,161,366 | |
| 2,202,167 | |
| 2,384,551 | |
| 3,384,916 | |
| 3,665,330 | |
| 3,949,604 | |
| 4,186,664 | |
| 3,514,997 | |
| 3,319,330 | |
| 3,087,325 | |
| 3,012,607 | |
| 3,597,446 | |
| 4,303,574 | |
| 5,013,218 | |
| 5,853,000 | |
| 5,950,000 | |
| 5,748,000 | |
| 4,976,443 | |
| 3,882,408 | |
| 3,002,324 | |
| 2,149,626 | |
| 1,808,782 | |
| 1,406,582 | |
| 938,939 |